Description
Cagrilintide is a synthetic long-acting analog of amylin, a pancreatic hormone involved in glucose and appetite regulation. It functions as an amylin receptor agonist in research settings.
Investigations have addressed satiety-related behavioral endpoints, glucose handling, gastric-emptying signaling, and amylin receptor activity across cell and rodent models. Its extended-action profile makes it suited to longer-interval metabolic study designs.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.